NCT04665583

Brief Summary

This study will aim to standardize the prehabilitation protocol to optimize patients and document the clinical and echo variables that could improve clinical outcomes of tricuspid valve intervention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 25, 2020

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

November 23, 2020

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 11, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

September 23, 2022

Status Verified

September 1, 2022

Enrollment Period

1 year

First QC Date

November 23, 2020

Last Update Submit

September 22, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in volume status according to daily input/outputs

    daily input/outputs (mL)

    4-5 days (Day 1 to Day 4 of Prehab or day of surgical intervention)

  • Change in volume status according to weight

    daily weights (kg)

    5-6 days (Baseline to Day 4 of Prehab or day of surgical intervention)

  • Change in Severity of Tricuspid Regurgitation by Echocardiographic assessment

    severity of tricuspid regurgitation (mild, moderate, severe)

    5 days (Baseline to Day 4 of Prehab)

  • Change in Nutritional Status

    Pre-albumin (mg/dL)

    4 days (Baseline to Day 3 of Prehab)

Study Arms (1)

Prehabilitation

All study patients will receive preoperative optimization with a standardized prehabilitation protocol prior to any intervention.

Other: Prehabilitation

Interventions

Prehabilitation will consist of careful pre-intervention assessment and personalized optimization, guided by Investigator judgment, with a specific focus on right ventricular function. This will be done by using a detailed echo acquisition protocol (Appendix 1). Assessments will be collected according to the schedule of events below (Table 1.). Therapy will include intravenous milrinone therapy and aggressive diuresis with evaluation for clinical and functional signs of improvement, according to standard of care.

Prehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

40 adult male or female patients undergoing tricuspid valve intervention at The Heart Hospital Baylor Plano

You may qualify if:

  • ≥ 18 years of age
  • Moderate-Severe or Severe TR
  • Undergoing tricuspid valve surgical or catheter-based intervention

You may not qualify if:

  • \. Clinical instability according to the judgement of the Investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baylor Scott & White Heart Hospital - Plano

Plano, Texas, 75093, United States

Location

Related Publications (3)

  • Zack CJ, Fender EA, Chandrashekar P, Reddy YNV, Bennett CE, Stulak JM, Miller VM, Nishimura RA. National Trends and Outcomes in Isolated Tricuspid Valve Surgery. J Am Coll Cardiol. 2017 Dec 19;70(24):2953-2960. doi: 10.1016/j.jacc.2017.10.039.

    PMID: 29241483BACKGROUND
  • Hamandi M, Smith RL, Ryan WH, Grayburn PA, Vasudevan A, George TJ, DiMaio JM, Hutcheson KA, Brinkman W, Szerlip M, Moore DO, Mack MJ. Outcomes of Isolated Tricuspid Valve Surgery Have Improved in the Modern Era. Ann Thorac Surg. 2019 Jul;108(1):11-15. doi: 10.1016/j.athoracsur.2019.03.004. Epub 2019 Apr 2.

    PMID: 30951698BACKGROUND
  • Hamandi M, George TJ, Smith RL, Mack MJ. Current outcomes of tricuspid valve surgery. Prog Cardiovasc Dis. 2019 Nov-Dec;62(6):463-466. doi: 10.1016/j.pcad.2019.11.014. Epub 2019 Dec 2.

    PMID: 31805294BACKGROUND

MeSH Terms

Conditions

Tricuspid Valve Insufficiency

Interventions

Preoperative Exercise

Condition Hierarchy (Ancestors)

Heart Valve DiseasesHeart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Perioperative CarePatient CareTherapeuticsSurgical Procedures, OperativeExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2020

First Posted

December 11, 2020

Study Start

October 25, 2020

Primary Completion

November 1, 2021

Study Completion

November 1, 2021

Last Updated

September 23, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

We do not have a plan to shared IPD to researchers outside of our research team. We will make available aggregate data and results in the form of publications. Internal BSWH monitors will have access to IPD.

Locations